AzTrials
AzTrials

End Stage Renal Disease on HemodialysisNCT02860312

Long Term Physical Activity for Hemodialysis Patients

A study testing Intradialytic exercise on stationary bicycles and Non-exercising group in people with End Stage Renal Disease on Hemodialysis, run by AURA Sante.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Patients on chronic hemodialysis present severe physical dysfunctioning associated with a significant reduction of their muscle mass. These two parameters are associated with increased morbidity and mortality along with deconditioning and poor quality of life. Read more about this study

Who is it for?
Ages 20 to 90 years
Conditions the study is for
End Stage Renal Disease on Hemodialysis
What is being tested?
Intradialytic exercise on stationary bicycles and Non-exercising group
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
100 participants
Where
No sites listed yet
Study dates
Sep 2016to May 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Consenting active hemodialysis patients since at least 6 months aged between 20 and 90 y.o.

Who cannot join

  • Unstable angina,
  • severe left ventricular dysfunction,
  • Ejection fraction < 30%,
  • severe peripheral arterial disease,
  • lower extremity amputation,
  • impossibility of physical effort: pain, uncontrolled bone/muscular disease,
  • participation on another study.

About this study

Official title: Effects of One Year Perdialytic Physical Activity on Aerobic Capacities and Quality of Life in Hemodialysis Patients

Patients on chronic hemodialysis present severe physical dysfunctioning associated with a significant reduction of their muscle mass. These two parameters are associated with increased morbidity and mortality along with deconditioning and poor quality of life. There are several studies- usually short term, single center uncontrolled and underpowered- that have shown a significant improvement of the physical, metabolic and dialytic parameters.

There are only few studies that have measured the impact of a long term intradialytic exercise intervention on a supervised manner. This is a multi-center controlled study examining the effects of intradialytic cycling on parameters of physical functioning, body composition, cardiovascular and nutritional status, immunological status and quality of life in a group of clinically stable hemodialysis patients

Read the detailed description

General Context Chronic Kidney Patients (CKD) live a sedentary life. Sedentarity and Sarcopenia worsen during the evolution of CKD with numerous cardiovascular diseases, infectious and other comorbidities. Inactivity may activate and amplify the inflammatory process, hypercoagulability, malnutrition, invoking a vicious circle of further inactivity and deconditioning.

These populations have a very low physical activity profile due to important tiredness, perturbed general condition and bad adaptation in effort. The patients with cardiovascular problems have additional limitations due to breathlessness associated with congestive cardiac failure and intermittent claudication due to peripheral arteriopathy. At the dialysis stages the tiredness is accentuated after the hemodialysis sessions. The days off dialysis are rarely used for practicing a physical activity.

The deconditioning along with the reduction of the physical activity are leading to a de-socializing progressing in the course of the chronic renal failure. In that way the patient feels more and more isolated with a serious eventual impact on the nutrition status and his quality of life.

Regular physical activity in this population of patients is exerting beneficial effects on insulin resistance, inflammation, dialysis efficiency, nutrition and arterial pressure. It may also reduce the intradialytic hypotensive episodes and improve quality of life, without side effects.

The objective of this study is to investigate an improvement of the physical functioning associated with a reprogramming of the autonomous nervous system, a reduction of the pro-inflammatory factors with a reduction of the insulin resistance (reduction of the metabolic syndrome), along with improvements on the immune system functioning for hemodialysis patients participating on a one year intradialytic physical activity program.

Principal objective :

The principal aim of the present study is to show the efficacy of intradialytic physical activity on functional capacity with the sit-to-stand test in 60 seconds (STS60) and the time to perform 5 complete sit-to-stand movements (STS5) along with a 6 minutes' walk test (6MWT).

Secondary objectives :

The secondary objectives are the amelioration of parameters associated with cardiovascular, sympathetic or autonomous nervous system, immune, nutritional, metabolic and inflammatory outcomes among with quality of life.

This is a multicenter, controlled randomized trial

Study description:

Inclusion of patients willing to participate in the study, and consequently their randomization in 2 groups.

The intervention group will benefit from a supervised physical activity during the dialysis session and the other group will carry on with his usual physical activities and have the same tests before and after the trial without undergoing a supervised intradialytic physical activity program

Primary judgment criteria :

The principal criteria will be the effect of an aerobic training program with a warming up phase, followed by 30 minutes of intradialytic cycling on 55% of the VO2max, 3 times a week.

The primary judgement criteria will be the improvement of the Sit-to-stand test in 60 seconds (STS60) and the time to complete 5 sit-to stand movements (STS5) as well as the 6 minutes' walk test (6MWT) from T0 (before the training program) to T12 (12 months after the start of the training period)

Secondary criteria:

  • Quality of life parameters evaluated from the questionaries SF36 (The Short Form (36) Health Survey), Borg scale, EVA.
  • Physical activity levels: IPAQ (international physical activity questionary).
  • Body composition (Fat mass, lean mass, bone mineral density, estimation of the muscular mass) with DEXA (dual-energy x-ray absorptiometry).
  • Cardiovascular parameters : Cardiac echography, doppler of the carotid arteries and the lower extremity arteries, 24h cardiac rhythm exploration
  • Immune parameters: leucocyte subpopulation functioning
  • Nutritional and metabolic parameters: weight, BMI, albumin, pre-albumin, pre- and post-dialytic serum urea and creatinine levels, nPCR (normalised Protein catabolic Rate).
  • Inflammatory parameters :(Interleucin) IL1 bêta, IL6, IL8, IL-10, TNF alpha (Tumor necrosis factor alpha), CRP (C reactive protein)
  • Dialysis parameters : Kt/v, anemia control : Hemoglobin (Hb), MCV (mean corpuscular volume), ferritin, erythropoetin dosage (EPO).
  • Number, etiology and duration of hospitalisations
  • Survival in 1 year

Number of participants : 100, ie 50 per group

Layout of the study :

Inclusion of the patient, evaluations at the start of the study protocol, at 6 months and at the end -12 months (M0, M6, M12).

Benefits and risks of this study :

Improvement of functional aerobic capacity, inflammatory status and quality of life. Improvements on the state of pain, autonomy, augmentation of the lean mass with conservation of the muscular mass for the lower extremities and reduction of the total fat mass are expected as well as improvement of the nutritional status, dialysis parameters, anemia control.

The risks are of cardiovascular origin: a possible decompensation of coronary artery disease, peripheral artery disease, taking into consideration that all patients benefit from echo doppler arterial control before the start of the study.

Regular Perdialytic Activity during Dialysis is practiced in AURA Auvergne (Association pour l'Utilisation du Rein Artificiel Santé) since 2 years; there has been no secondary vascular problem associated with the supervised physical activity. Nevertheless, rare tendon problems or articular and muscular pains could be possible on the course of the study

Being tested
Intradialytic exercise on stationary bicycles, Non-exercising group

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intradialytic exercise on stationary bicyclesBehavioural

    Patients are exercising for 30-60 min during dialysis on an Rated Perceived Exertion (RPE) Scale between 12 and 14

  • Non-exercising groupBehavioural

    Patients are having their usual physical activity

Study groups in NCT02860312
Study groupRoleWhat they receive
ExercisersActive comparatorIntradialytic exercise on stationary bicycles
Receives: Behavioral: Intradialytic exercise on stationary bicycles
Non ExercisersPlacebo comparatorNo intradialytic exercise
Receives: Behavioral: Non-exercising group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Improvement of the distance covered after walking for 6 minutes (6 minutes walk test)

    The principal aim of the present study is to show the efficacy of intradialytic physical activity on the improvement of the physical capacity of the patients assessed with the 6 minutes walk test ((6MWT)

    Measured: 12 months

Secondary outcomes (29)
  1. Quality of life parameters 1

    Quality of life parameters evaluated from the questionnaire SF36 QD

    Measured: 12 months

  2. Quality of life parameters 2

    Quality of life parameters evaluated from the questionnaire Borg scale

    Measured: 12 months

  3. Quality of life parameters 3

    Quality of life parameters evaluated from the EVA scale

    Measured: 12 months

  4. Physical activity levels

    Physical activity levels from the questionnary IPAQ (international physical activity questionnairy)

    Measured: 12 months

  5. Body composition

    Body composition (Fat mass, lean mass, bone mineral density, estimation of the muscular mass) with DEXA ccanning and bioimpendance

    Measured: 12 months

  6. Cardiovascular parameters

    Cardiovascular parameters : Cardiac echography, echodoppler of the carotid arteries and the lower extremity arteries, 24h cardiac rythm exploration

    Measured: 12 months

  7. Immune parametres

    Immune parametres: leucocyte subpopulation fonctioning

    Measured: 12 months

  8. Nutritional and metabolic parameters 1

    BMI

    Measured: 12 months

  9. Nutritional and metabolic parameters 2

    serum albumin levels

    Measured: 12 months

  10. Nutritional and metabolic parameters 3

    serum prealbumin levels

    Measured: 12 months

  11. Nutritional and metabolic parameters 4

    pre and post dialytic serum urea levels

    Measured: 12 months

  12. Nutritional and metabolic parameters 5

    pre and post dialytic serum creatinine levels

    Measured: 12 months

  13. Nutritional and metabolic parameters 6

    nPCR (normalised Protein Catabolic Rate)

    Measured: 12 months

  14. inflammatory parameters 1

    IL1 bêta

    Measured: 12 months

  15. inflammatory parameters 2

    IL6

    Measured: 12 months

  16. inflammatory parameters 3

    IL8

    Measured: 12 months

  17. inflammatory parameters 4

    IL-10

    Measured: 12 months

  18. inflammatory parameters 5

    TNF alpha

    Measured: 12 months

  19. inflammatory parameters 6

    CRP

    Measured: 12 months

  20. Dialysis parameters

    Kt/V

    Measured: 12 months

  21. Anemia control 1

    Hemoglobin (Hb)

    Measured: 12 months

  22. Anemia control 2

    MCV (mean corpuscular volume)

    Measured: 12 months

  23. Anemia control 3

    Ferritine

    Measured: 12 months

  24. Anemia control 4

    Erythropoetine dosage (EPO).

    Measured: 12 months

  25. Number of hospitalisations

    Number of hospitalisations

    Measured: 12 months

  26. Duration of hospitalisations

    Duration of hospitalisations

    Measured: 12 months

  27. Survival

    Survival in one year

    Measured: 12 months

  28. Improvement of Sit to Stand test in 60 seconds (STS60)

    The physical capacity of the patients assessed with the number of cycles performed during a sit-to-stand test in 60 seconds (STS60).

    Measured: 12 months

  29. Improvement of the time needed to perform 5 Sit to Stand cycles (STS5)

    Time needed to perform 5 Sit to Stand cycles (STS5)

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Aug 2016 (estimated)
  2. Study startSep 2016
  3. Primary completionSep 2018 (estimated)
  4. Study completionMay 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02860312
Sponsor's protocol ID
AURAS
Other IDs
ID-RCB 2015-A0031-48
Status last verified
Aug 2016
First submitted
14 Jul 2016
Last updated
9 Aug 2016
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Intradialytic exercise on stationary bicycles and Non-exercising group in people with End Stage Renal Disease on Hemodialysis, run by AURA Sante.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Aug 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Improvement of the distance covered after walking for 6 minutes (6 minutes walk test) (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Aug 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in